MedTrace Logo

Contralateral Neurodynamic Mobilisation Improves Hamstring Flexibility.

NCT07648732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-06-15

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate whether single limb neurodynamic mobilizations increase active knee extension (AKE) range of motion (ROM) of the contralateral limb. 20 healthy participants (10 females and 10 males, age; 20.8+1.7 years, height; 1.7+ 0.1m, weight; 76.7+ 15.4kg). AKE was measured pre- and post- intervention and control. The main question it aims to answer are:

It is hypothesized that contralateral neurodynamic mobilization will significantly increase AKE ROM in asymptomatic individuals.

Participants were allocated sequentially in an alternating order to study groups. This method aims to balance group sizes while simplifying the assignment. AKE was measured immediately before and after the allocated condition. One week later, at the same time of day, participants returned to complete the opposing condition following a standardized washout period to minimize carryover effects between conditions.

* Completed a neurodynamic mobilisation on the contralateral limb 6x30seconds, 10 second rest between sets.
* When acting as the control sat quietly for 4 minutes to match the duration of the intervention condition.

Conditions

  • Range of Motion
  • Neuromuscular Signs and Symptoms
  • Wounds and Injury

Interventions

OTHER

Neurodynamic Hamstring Mobilisation

Sciatic Neurodynamic slider performed on the right leg.

Sponsors & Collaborators

  • University of Salford

    lead OTHER

Principal Investigators

  • Charlotte A Park, MSc · University of Salford

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-04-30
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07648732 on ClinicalTrials.gov